Literature DB >> 1631162

Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation.

R Kumar1, I Atlas.   

Abstract

Interferon alpha (IFN-alpha) is a regulatory secretory protein with distinctive biological effects such as antiproliferative actions against many tumor cell lines, including human Burkitt lymphoma Daudi cells. The mechanism underlying growth inhibition by IFN-alpha is not well established. The growth of many mammalian cell types is also regulated by tumor suppressor retinoblastoma (RB) gene product, the RB protein. In the studies presented here, we explored the possible involvement of RB protein in the growth inhibitory action of IFN-alpha in the Daudi cell model system. We observed that IFN-alpha induces a 3- to 10-fold increased expression of RB protein in growth-sensitive Daudi cells but not in the growth-resistant variant of Daudi cells. IFN-alpha-mediated induction of RB protein was an early event that preceded the period of growth inhibition of Daudi cells. IFN-alpha-induced RB protein predominantly exists as the underphosphorylated form. Addition of antibody against IFN-alpha to Daudi cells resulted in the inhibition of constitutive expression of RB protein and stimulation of [3H]thymidine incorporation. These results demonstrate that the induction of RB protein expression in IFN-alpha-treated Daudi cells could constitute an important mechanism of IFN-alpha-mediated growth regulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1631162      PMCID: PMC49549          DOI: 10.1073/pnas.89.14.6599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights.

Authors:  H L Moses; E Y Yang; J A Pietenpol
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

2.  Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation.

Authors:  M Laiho; J A DeCaprio; J W Ludlow; D M Livingston; J Massagué
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

3.  Interferons and oncogenes.

Authors:  M Clemens
Journal:  Nature       Date:  1985 Feb 14-20       Impact factor: 49.962

4.  Clonal derivatives of the RD-114 cell line differ in their antiviral and gene-inducing responses to interferons.

Authors:  R Kumar; R K Tiwari; J Kusari; G C Sen
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

5.  Spontaneous production of high levels of leukocyte (alpha) interferon by a human lymphoblastoid B-cell line (LDV/7).

Authors:  D V Ablashi; S Baron; G Armstrong; A Faggioni; D Viza; P H Levine; G Pizza
Journal:  Proc Soc Exp Biol Med       Date:  1982-10

6.  Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly.

Authors:  M J Van de Vijver; R Kumar; J Mendelsohn
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

7.  Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells.

Authors:  R Kumar; H M Shepard; J Mendelsohn
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

8.  Correlation between retinoblastoma gene expression and differentiation in human testicular tumors.

Authors:  T Strohmeyer; P Reissmann; C Cordon-Cardo; M Hartmann; R Ackermann; D Slamon
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

9.  Close link between reduction of c-myc expression by interferon and, G0/G1 arrest.

Authors:  M Einat; D Resnitzky; A Kimchi
Journal:  Nature       Date:  1985 Feb 14-20       Impact factor: 49.962

10.  Functional equivalents of interferon-mediated signals needed for induction of an mRNA can be generated by double-stranded RNA and growth factors.

Authors:  R K Tiwari; J Kusari; G C Sen
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  12 in total

1.  Cell cycle-dependent modulation of telomerase activity in tumor cells.

Authors:  X Zhu; R Kumar; M Mandal; N Sharma; H W Sharma; U Dhingra; J A Sokoloski; R Hsiao; R Narayanan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  GRIM-19 and p16(INK4a) synergistically regulate cell cycle progression and E2F1-responsive gene expression.

Authors:  Peng Sun; Shreeram C Nallar; Abhijit Raha; Sudhakar Kalakonda; Chidambaram N Velalar; Sekhar P Reddy; Dhananjaya V Kalvakolanu
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

3.  Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents.

Authors:  Z Lin; S Lim; M A Viani; M Sapp; M S Lim
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  The polyoma virus T antigen interferes with interferon-inducible gene expression.

Authors:  X Weihua; S Ramanujam; D J Lindner; R D Kudaravalli; R Freund; D V Kalvakolanu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

5.  Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells.

Authors:  B H Morrison; J A Bauer; D V Kalvakolanu; D J Lindner
Journal:  J Biol Chem       Date:  2001-05-03       Impact factor: 5.157

6.  Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid.

Authors:  E R Hofmann; M Boyanapalli; D J Lindner; X Weihua; B A Hassel; R Jagus; P L Gutierrez; D V Kalvakolanu; E R Hofman
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

7.  Maximal induction of a subset of interferon target genes requires the chromatin-remodeling activity of the BAF complex.

Authors:  Hong Liu; Hyeog Kang; Rui Liu; Xin Chen; Keji Zhao
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

Review 8.  Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation.

Authors:  Hui Mu; Xiaojian Zhu; Hui Jia; Lu Zhou; Hong Liu
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

9.  Antiproliferative Properties of Type I and Type II Interferon.

Authors:  Joseph Bekisz; Samuel Baron; Corey Balinsky; Angel Morrow; Kathryn C Zoon
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-30

Review 10.  Re-emergence of interferon-α in the treatment of chronic myeloid leukemia.

Authors:  M Talpaz; R Hehlmann; A Quintás-Cardama; J Mercer; J Cortes
Journal:  Leukemia       Date:  2012-11-07       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.